
Looking to sell Abridge stock or options?
Abridge has developed an AI-driven conversation analysis tool aimed at adding context and understanding to medical discussions. This application leverages machine learning to provide an audio-based system that records and summarizes medical conversations, offering insights and clarity. It enables users to adhere to doctors' recommendations, reduces administrative tasks, improves documentation precision, enhances patient comprehension, and optimizes workflows across clinical, nursing, and revenue cycle operations.







SV Angel, Leonis Investissement, Atria Ventures, NVentures (Santa Clara), Whistler Capital Partners, Pillar VC, Elad Gil, Mayo Clinic, Union Square Ventures, Mana Ventures.
San Oo has been named chief technology officer of healthcare AI startup Abridge. Mr. Oo was most recently senior vice president of engineering at AI workspace developer Notion. He previously cofounded two tech companies that were acquired by Linke...
Read moreAbridge is partnering with top medical journals to bring in research for doctors to refer during visits, pitting it against OpenEvidence as more companies push to become all-in-one platforms for doctors.
Read moreAI clinical conversation platform Abridge is partnering with health information network Availity to launch a real-time prior authorization tool integrated into clinician workflows. The collaboration connects Abridge’s AI platform, used by more tha...
Read moreAI medical scribe company Abridge's closest partner and former shareholder, health records giant Epic, has become its biggest threat.
Read moreAbridge is looking for acquisitions after raising $700 million in 18 months. Here's what the red-hot health AI startup wants in a deal.
Read moreAbridge's CEO reveals how the company's AI expertise will be leveraged in a partnership with a major Pittsburgh health system.
Read more